NCT05209204

Brief Summary

The aim of this study is to detect PACG suspects using both AS OCT and Scheimpflug imaging.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

January 7, 2022

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 26, 2022

Completed
Last Updated

January 26, 2022

Status Verified

January 1, 2022

Enrollment Period

8 months

First QC Date

January 7, 2022

Last Update Submit

January 25, 2022

Conditions

Keywords

Angle closureASOCT

Outcome Measures

Primary Outcomes (6)

  • Anterior segment parameters as measured by AS-OCT:

    Anterior chamber depth (ACD)..

    3 months

  • Anterior segment parameters as measured by Oculus Pentacam:

    Anterior chamber angle (ACA).

    3 months

  • Anterior segment parameters by ASOCT

    Angle opening distance at 750 µm (AOD750).

    3 months

  • Anterior segment parameters by OCT

    Anterior chamber angle (ACA).

    3 months

  • Pentacam parameters

    Anterior chamber volume (ACV).

    3 months

  • Pentacam parameters by Oculus Pentacam:

    Anterior chamber depth (ACD).

    3 months

Study Arms (1)

40 pateint glucoma suspect

ASOCT

Diagnostic Test: ASOCTDiagnostic Test: Pentacam

Interventions

ASOCTDIAGNOSTIC_TEST

Anterior segment imaging using RTVue XR 100 Avanti OCT platform (Optovue Inc.,Fairmont, CA).

40 pateint glucoma suspect
PentacamDIAGNOSTIC_TEST

Anterior segment imaging using Oculus Pentacam HR (Oculus Optikgeräte, Wetzlar, Germany).

40 pateint glucoma suspect

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Residents of Minia Governorate diagnosed with SLE with renal affection and without renal affection.

You may qualify if:

  • Hyperopes. 2-Shallow AC. 3-With gonioscopy carried out under dim-light conditions without indentation ,with the eye in primary position there is inability to visualize ≤ 180° of the posterior trabecular meshwork (TM) in the absence of peripheral anterior 4-IOP ≤ 21 as measured by tonometry. 5-Normal visual field on static automated perimetry (SAP) testing. 5-Normal optic nerve head (ONH) appearance on fundus biomicroscopy. 6-Family history of primary angle closure disease.

You may not qualify if:

  • Eyes with significant corneal opacity that can impare signal strings of any of the used imaging modalities.
  • Eyes wih history of intraocular surgery (e.g. cataract surgery ,retinal detachment surgery).
  • Eyes with history of laser procedures (e.g.laser peripheral iridotomy). 4-Eyes with anterior segment pathology as iridocyclitis or angle disgenesis 5. Eyes with history of trauma. 6- Eyes with findings suggestive of 2dry cause of glaucoma (e.g. iris or angle neovascularization, any iris or corneal abnormalities, dilated episcleral vessels ).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Minia University hospital

Minya, Egypt

Location

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Mohamed Salah

    Minia University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 7, 2022

First Posted

January 26, 2022

Study Start

April 1, 2019

Primary Completion

December 1, 2019

Study Completion

January 1, 2020

Last Updated

January 26, 2022

Record last verified: 2022-01

Locations